Evidence map›Paper›PMID 19372301›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2009

Transpulmonary passage of 99mTc macroaggregated albumin in healthy humans at rest and during maximal exercise.

Andrew T Lovering, Hans C Haverkamp, Lee M Romer, John S Hokanson, Marlowe W Eldridge

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. The Pulmonary Vasculature.Seminars in respiratory and critical care medicine · 2023
    Review
  5. Lung functional imaging.Breathe (Sheffield, England) · 2023
    Article
  6. Review
  7. Review
  8. Minute ventilation/carbon dioxide production in congenital heart disease.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats.Journal of controlled release : official journal of the Controlled Release Society · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew T LoveringDepartment of Human Physiology, University of Oregon, Eugene, OR 97403-1240, USA. lovering@uoregon.edu
Hans C Haverkamp
Lee M Romer
John S Hokanson
Marlowe W Eldridge

Funding

Respiratory NeurobiologyT32HL007654 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MITCHELL, GORDON S. · 1987 to 2011
$4.0M
HUMAN VENTILATORY ADAPTIONR01HL015469 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI DEMPSEY, JEROME A · 1985 to 2011
$3.7M
Comprehensive Characterization of Intrapulmonary Arteriovenous Pathways in HealthR01HL086897 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI ELDRIDGE, MARLOWE · 2008 to 2012
$1.8M
HUMAN VENTILLATORY ADAPTATIONR37HL015469 · NHLBI · UNIVERSITY OF WISCONSIN MADISON · PI DEMPSEY, JEROME A · 1988 to 1996
–
NHLBI NIH HHS HL-15469NHLBI NIH HHS R01 HL086897NHLBI NIH HHS T32 HL07654
6 · The paper itself

Abstract

We have demonstrated that 50-mum-diameter arteriovenous pathways exist in isolated, healthy human and baboon lungs, ventilated and perfused under physiological pressures. These findings have been confirmed and extended by demonstrating the passage of 25-microm microspheres through the lungs of exercising dogs, but not at rest. Determination of blood flow through these large-diameter intrapulmonary arteriovenous pathways would be an important first step to establish a physiological role for these vessels. Currently, we sought to estimate blood flow through these arteriovenous pathways using technetium-99m ((99m)Tc)-labeled macroaggregated albumin (MAA) in healthy humans at rest and during maximal treadmill exercise. We hypothesized that the percentage of (99m)Tc MAA able to traverse the pulmonary circulation (%transpulmonary passage) would increase during exercise. Seven male subjects without patent foramen ovale were injected with (99m)Tc MAA at rest on 1 day and during maximal treadmill exercise on a separate day (>6 days). Within 5 min after injection, subjects began whole body imaging in the supine position. Six of the seven subjects showed an increase in transpulmonary passage of MAA with maximal exercise. Using two separate analysis methods, percent transpulmonary passage significantly increased with exercise from baseline to absolute values of 1.2 +/- 0.8% (P = 0.008) and 1.3 +/- 1.0% (P = 0.016), respectively (means +/- SD; paired t-test). We conclude that MAA may be traversing the pulmonary circulation via large-diameter intrapulmonary arteriovenous conduits in healthy humans during exercise. Recruitment of these pathways may divert blood flow away from pulmonary capillaries during exercise and compromise the lung's function as a biological filter.

Indexed as

Exercise TestRadiopharmaceuticalsTechnetium Tc 99m Aggregated AlbuminAdultEchocardiographyExerciseHumansLungMalePulmonary CirculationPulmonary Gas ExchangeYoung AdultRadiopharmaceuticalsTechnetium Tc 99m Aggregated Albumin

Identifiers

PMID19372301
PMCPMC2692773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.